Produção Nacional
Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides - 2023
2023; Volume: 4; Issue: 2 Linguagem: Inglês
10.46765/2675-374x.2023v4n2p200
ISSN2675-374X
AutoresAnderson João Simione, Heliz Regina A. Neves, Cinthya Corrêa da Silva, Paula Moreira da Silva Sabaini, Bruna Letícia da Silva Santos Geraldo, Leonardo Jun Otuyama, Marcelo C. Pasquini, Vergílio Antônio Rensi Colturato, Samir Kanaan Nabhan, Vanderson Rocha, Carmen Silvia Vieitas Vergueiro, Adriana Seber, Alexandre Silvério, Maria Cláudia Rodrigues Moreira, George Maurício Navarro Barros, Cláudia Caceres Astigarraga, Liane Esteves Daudt, Maria Cristina Martins de Almeida Macedo, Ricardo Chiattone, Yana Novis, Juliana Folloni Fernandes, Volney Assis Lara Vilela, Décio Lerner, Rodolfo Daniel de Almeida Soares, Phillip Scheinberg, Gustavo Machado Teixeira, Celso Arrais‐Rodrigues, Marcos Paulo Colella, Roberto Luiz da Silva, Vaneuza Araújo Moreira Funke, Afonso Celso Vigorito, Leonardo Javier Arcuri, Nelson Hamerschlak, Jayr Schmidt Filho, Vinícius Campos de Molla, João Samuel de Holanda Farias, Ricardo Pasqüini, Carmem Bonfim, Abrahão Elias Hallack Neto, Rodolfo Calixto, Monique Ammi, Luís Fernando Bouzas, João Victor Piccolo Feliciano, Rafael Dezen Gaiolla, Marcelo Capra, Ângelo Atalla, Milton A. F. Aranha, Rony Schaffel, Gianne Donato Costa Veloso, Antônio Vaz de Macedo, Fernando Barroso Duarte,
Tópico(s)Hematopoietic Stem Cell Transplantation
ResumoThe first hematopoietic stem cell transplantation (HSCT) program in Latin America started in 1979 at the federal university hospital in Curitiba, Paraná, Brazil. Over the years, the number of centers performing transplants in our country has increased tremendously, generating the need to know the results of this treatment modality. Understanding the HSCT scenario in Brazil is still challenging, since not all Brazilian centers report data to the Center for International Blood and Marrow Research (CIBMTR). Despite the improvement in the number of reporting centers over the past few years, infrastructure and trained data managers are still lacking. The partnership between the Brazilian Cellular Therapy and Bone Marrow Transplant Society (SBTMO) and the CIBMTR enabled the establishment of the Hematopoietic Stem Cell Transplantation Brazilian Registry (HSCTBR), using the CIBMTR Data Back to Center (DBtC) tool to retrieve Brazilian HSCT data in a standardized and organized way. Since then, it has been possible to gather country-level data on HSCT demographics and transplant outcomes. Between 2012 and 2022, complete information on 9,868 transplants were reported to the CIBMTR from 40 Brazilian transplant centers. The consolidation of the HSCTBR using CIBMTR infrastructure allowed the development and regular update of the Brazilian Summary Slides. Despite the differences in the number of cases and follow-up time, the results in this study were similar to those presented in the United States (US) Summary Slides. In this paper we present the 2023 SBTMO-CIBMTR Summary Slides prepared by the SBTMO data managers (GD-SBTMO).
Referência(s)